Provided by Tiger Trade Technology Pte. Ltd.

SH PHARMA

11.110
+0.1000.91%
Volume:983.40K
Turnover:10.90M
Market Cap:41.20B
PE:6.12
High:11.190
Open:11.190
Low:10.990
Close:11.010
52wk High:12.170
52wk Low:10.474
Shares:3.71B
HK Float Shares:919.07M
Volume Ratio:0.53
T/O Rate:0.11%
Dividend:0.53
Dividend Rate:4.78%
EPS(LYR):1.816
ROE:6.96%
ROA:2.34%
PB:0.45
PE(LYR):6.12
PS:0.12

Loading ...

Shanghai Pharma Posts Higher Q3 Attributable Net Profit; Revenue Up

MT Newswires Live
·
Yesterday

SH Pharma Renews RMB90.00 Million Packaging Procurement Agreement with Wing Fat Printing for 2027

Bulletin Express
·
Yesterday

Shanghai Pharmaceuticals renews three-year property leasing deal with parent for up to RMB1.00 billion rent in total

Bulletin Express
·
Yesterday

SH Pharma Posts Strong Underlying Earnings in Q3 2026; Nine-Month Cash Flow Surges 128%

Bulletin Express
·
Yesterday

SH PHARMA Schedules 29 October Board Meeting to Approve Q3 2026 Results

Bulletin Express
·
Oct 16

Shanghai Pharmaceuticals' Unit Gets Registration Certificates for Clevidipine Injectable Emulsion

MT Newswires Live
·
Oct 12

Shanghai Pharmaceuticals (601607.SH) Receives Approval to Manufacture Clevidipine Emulsion Injection

Stock News
·
Oct 09

SH PHARMA Reports Stable Share Base and Confirms Sufficient Public Float for September 2026

Bulletin Express
·
Oct 02

Shanghai Pharma Gets Registration Certificate for Isavuconazole Sulfate for Injection

MT Newswires Live
·
Sep 29

Shanghai Pharmaceuticals Gets Registration Certificate for Paclitaxel Injection

MT Newswires Live
·
Sep 29

Shanghai Pharmaceuticals Secures Production Approval for Isavuconazonium Sulfate for Injection

Stock News
·
Sep 28

Rooted in Zhangjiang, Connected to the World: SH Pharma Powers an Open Innovation Ecosystem as an Ecosystem Anchor

Deep News
·
Sep 22

Shanghai Pharma H1 Revenue Rises 4.2%, Core Profit Rebounds but One-offs Drag Net Down 21%

Bulletin Express
·
Sep 17

Shanghai Pharmaceuticals Declares Interim Dividend

MT Newswires Live
·
Sep 11

Shanghai Pharmaceuticals' Subsidiary Receives Generic Drug Consistency Evaluation Approval for Lincomycin Hydrochloride Injection

Stock News
·
Sep 10

Shanghai Pharmaceuticals Uniti Gets China Drug Registration Nod for Blood Cancer Tablets

MT Newswires Live
·
Sep 01

Shanghai Pharmaceuticals Receives Production Approval for Ruxolitinib Phosphate Tablets

Stock News
·
Aug 31

Shanghai Pharma Posts Lower H1 Attributable Profit; Revenue Up

MT Newswires Live
·
Aug 27

SH PHARMA Declares Interim Dividend of RMB 0.10 per Share for First-Half 2026

Bulletin Express
·
Aug 27

SH Pharma Reports Mixed H1 2026: Revenue Rises 4.15%, Net Profit Slips 21.40%, Proposes Cash Dividend

Bulletin Express
·
Aug 27